Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T cell Therapy for Acute Lymphoblastic Leukemia.

Teachey DT, Lacey SF, Shaw PA, Melenhorst JJ, Maude SL, Frey N, Pequignot E, Gonzalez VE, Chen F, Finklestein J, Barrett DM, Weiss SL, Fitzgerald JC, Berg RA, Aplenc R, Callahan C, Rheingold SR, Zheng Z, Rose-John S, White JC, Nazimuddin F, Wertheim G, Levine BL, June CH, Porter DL, Grupp SA.

Cancer Discov. 2016 Apr 13. pii: CD-16-0040. [Epub ahead of print]

PMID:
27076371
2.

Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy.

Chen F, Teachey DT, Pequignot E, Frey N, Porter D, Maude SL, Grupp SA, June CH, Melenhorst JJ, Lacey SF.

J Immunol Methods. 2016 Apr 3. pii: S0022-1759(16)30054-0. doi: 10.1016/j.jim.2016.03.005. [Epub ahead of print]

PMID:
27049586
3.

Outcomes of Sequential Glaucoma Drainage Implants in Refractory Glaucoma.

Hu WD, Moster MR, Zheng CX, Sabherwal N, Pequignot E, Cvintal V, Ekici F, Waisbourd M.

J Glaucoma. 2016 Apr;25(4):e340-5. doi: 10.1097/IJG.0000000000000362.

PMID:
26709499
4.

Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice.

Liu X, Jiang S, Fang C, Yang S, Olalere D, Pequignot EC, Cogdill AP, Li N, Ramones M, Granda B, Zhou L, Loew A, Young RM, June CH, Zhao Y.

Cancer Res. 2015 Sep 1;75(17):3596-607. doi: 10.1158/0008-5472.CAN-15-0159.

PMID:
26330166
5.

INCIDENCE OF SUSTAINED OCULAR HYPERTENSION USING PREPACKAGED VERSUS FRESHLY PREPARED INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Storey PP, Ho V, Yeh S, Reddy S, Fang-Yen NH, Pequignot E, Leiby BE, Fineman M, Garg S, Hubbard GB 3rd, Hsu J.

Retina. 2015 Oct;35(10):1992-2000. doi: 10.1097/IAE.0000000000000620.

PMID:
26035396
6.

The HYSLAR trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy.

Lavu H, Sell NM, Carter TI, Winter JM, Maguire DP, Gratch DM, Berman RA, Feil MG, Grunwald Z, Leiby BE, Pequignot EC, Rosato EL, Yeo CJ.

Ann Surg. 2014 Sep;260(3):445-53; discussion 453-5. doi: 10.1097/SLA.0000000000000872.

PMID:
25115420
7.

Retinal hemorrhage in abusive head trauma: finding a common language.

Levin AV, Cordovez JA, Leiby BE, Pequignot E, Tandon A.

Trans Am Ophthalmol Soc. 2014;112:1-10.

8.

Metabolic syndrome increases risk for pulmonary embolism after hip and knee arthroplasty.

Mraovic B, Hipszer BR, Epstein RH, Parvizi J, Pequignot EC, Chervoneva I, Joseph JI.

Croat Med J. 2013 Aug;54(4):355-61.

9.

Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Assifi MM, Zhang S, Leiby BE, Pequignot EC, Xia B, Rosato E, Lavu H, Kennedy EP, Yeo CJ, Berger AC.

J Am Coll Surg. 2013 Oct;217(4):621-7. doi: 10.1016/j.jamcollsurg.2013.05.014. Epub 2013 Jun 28.

PMID:
23810574
10.

Splenic vein thrombosis is associated with an increase in pancreas-specific complications and reduced survival in patients undergoing distal pancreatectomy for pancreatic exocrine cancer.

Dedania N, Agrawal N, Winter JM, Koniaris LG, Rosato EL, Sauter PK, Leiby B, Pequignot E, Yeo CJ, Lavu H.

J Gastrointest Surg. 2013 Aug;17(8):1392-8.

PMID:
23797883
11.

Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.

Peck AR, Witkiewicz AK, Liu C, Klimowicz AC, Stringer GA, Pequignot E, Freydin B, Yang N, Ertel A, Tran TH, Girondo MA, Rosenberg AL, Hooke JA, Kovatich AJ, Shriver CD, Rimm DL, Magliocco AM, Hyslop T, Rui H.

Breast Cancer Res. 2012 Oct 4;14(5):R130. doi: 10.1186/bcr3328.

12.

Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?

Valsecchi ME, Holdbrook T, Leiby BE, Pequignot E, Littman SJ, Yeo CJ, Brody JR, Witkiewicz AK.

BMC Cancer. 2012 Mar 22;12:104. doi: 10.1186/1471-2407-12-104.

13.

High blood pressure and obesity increase the risk of abnormal glucose tolerance in young adult african americans.

Huan Y, DeLoach S, Keith SW, Pequignot EC, Falkner B.

J Clin Hypertens (Greenwich). 2011 Jun;13(6):397-403. doi: 10.1111/j.1751-7176.2010.00421.x. Epub 2011 Jan 31.

14.

Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.

Peck AR, Witkiewicz AK, Liu C, Stringer GA, Klimowicz AC, Pequignot E, Freydin B, Tran TH, Yang N, Rosenberg AL, Hooke JA, Kovatich AJ, Nevalainen MT, Shriver CD, Hyslop T, Sauter G, Rimm DL, Magliocco AM, Rui H.

J Clin Oncol. 2011 Jun 20;29(18):2448-58. doi: 10.1200/JCO.2010.30.3552. Epub 2011 May 16.

15.

Latency to first seizure after temporal lobectomy predicts long-term outcome.

Buckingham SE, Chervoneva I, Sharan A, Zangaladze A, Mintzer S, Skidmore C, Nei M, Evans J, Pequignot E, Sperling MR.

Epilepsia. 2010 Oct;51(10):1987-93.

PMID:
21069902
16.

Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant.

Stoch SA, Gargano C, Valentine J, Braun MP, Murphy MG, Fedgchin M, Majumdar A, Pequignot E, Gottesdiener KM, Petty KJ, Panebianco D, Dean D, Kraft WK, Greenberg HE.

Cancer Chemother Pharmacol. 2011 Jun;67(6):1313-21. doi: 10.1007/s00280-010-1421-y. Epub 2010 Aug 24.

PMID:
20734049
17.

Prognostic significance of high-grade dysplasia in colorectal adenomas.

Toll AD, Fabius D, Hyslop T, Pequignot E, DiMarino AJ, Infantolino A, Palazzo JP.

Colorectal Dis. 2011 Apr;13(4):370-3. doi: 10.1111/j.1463-1318.2010.02385.x.

PMID:
20718835
18.

Risk factors associated with urinary albumin excretion in African Americans.

Ussai KE, Keith SW, Pequignot E, Falkner B.

J Hum Hypertens. 2011 Jan;25(1):3-10. doi: 10.1038/jhh.2010.79. Epub 2010 Jul 29.

PMID:
20668471
19.

Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.

Fogh SE, Andrews DW, Glass J, Curran W, Glass C, Champ C, Evans JJ, Hyslop T, Pequignot E, Downes B, Comber E, Maltenfort M, Dicker AP, Werner-Wasik M.

J Clin Oncol. 2010 Jun 20;28(18):3048-53. doi: 10.1200/JCO.2009.25.6941. Epub 2010 May 17. Erratum in: J Clin Oncol. 2010 Sep 20;28(27):4280.

20.

Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT.

Pe ML, Trabulsi EJ, Kedika R, Pequignot E, Dicker AP, Gomella LG, Valicenti RK.

Urology. 2009 Jun;73(6):1328-34. doi: 10.1016/j.urology.2008.09.078. Epub 2009 Apr 18.

PMID:
19376564
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk